Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Retained Earnings: 2022-2024

Historic Retained Earnings for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Dec 2024 value amounting to -$309.9 million.

  • Orchestra BioMed Holdings' Retained Earnings fell 25.57% to -$368.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$368.8 million, marking a year-over-year decrease of 25.57%. This contributed to the annual value of -$309.9 million for FY2024, which is 24.52% down from last year.
  • Orchestra BioMed Holdings' Retained Earnings amounted to -$309.9 million in FY2024, which was down 24.52% from -$248.9 million recorded in FY2023.
  • Orchestra BioMed Holdings' Retained Earnings' 5-year high stood at -$199.7 million during FY2022, with a 5-year trough of -$309.9 million in FY2024.
  • For the 3-year period, Orchestra BioMed Holdings' Retained Earnings averaged around -$252.8 million, with its median value being -$248.9 million (2023).
  • Data for Orchestra BioMed Holdings' Retained Earnings shows a maximum YoY declined of 24.59% (in 2023) over the last 5 years.
  • Yearly analysis of 3 years shows Orchestra BioMed Holdings' Retained Earnings stood at -$199.7 million in 2022, then decreased by 24.59% to -$248.9 million in 2023, then decreased by 24.52% to -$309.9 million in 2024.